5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.12▼ | 2.12▼ | 2.12▼ | 2.09▼ | 2.23▼ |
MA10 | 2.10▼ | 2.10▼ | 2.10▼ | 2.15▼ | 2.72▼ |
MA20 | 2.14▼ | 2.16▼ | 2.18▼ | 2.26▼ | 3.36▼ |
MA50 | 2.28▼ | 2.29▼ | 2.36▼ | 2.85▼ | 9.47▼ |
MA100 | 2.65▼ | 2.72▼ | 2.81▼ | 3.53▼ | 69.81▼ |
MA200 | 2.99▼ | 3.12▼ | 3.21▼ | 7.49▼ | 1,940.02▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.008▲ | 0.009▲ | 0.011▲ | 0.014▲ | 0.816▲ |
RSI | 38.209▼ | 37.464▼ | 36.884▼ | 34.958▼ | 33.286▼ |
STOCH | 57.619 | 57.619 | 50.568 | 25.812 | 3.880▼ |
WILL %R | -47.619 | -47.619 | -57.692 | -85.714▼ | -97.143▼ |
CCI | -52.214 | -61.026 | -67.407 | -71.530 | -120.283▼ |
MA | $ADTX Price Crossed Below MA(7) | Set Alert |
Wednesday, May 15, 2024 12:07 PM
Aditxt (NASDAQ: ADTX) recently provided Evofem Biosciences Inc. (OTCQB: EVFM) $1 million in consideration for reinstating and amending the merger ag ...
|
Wednesday, May 15, 2024 06:02 AM
The company behind the hormone-free contraceptive Phexxi® (lactic acid, citric acid and potassium bitartrate), Evofem Biosciences, Inc. ("Evofem" or "the Company") ...
|
Tuesday, May 14, 2024 05:00 PM
Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/05/24 | 2.18 | 2.225 | 1.97 | 2.05 | 24,554 |
14/05/24 | 2.10 | 2.2499 | 2.10 | 2.20 | 54,605 |
13/05/24 | 2.07 | 2.07 | 2.07 | 2.07 | 12,471 |
10/05/24 | 2.10 | 2.2399 | 2.04 | 2.07 | 32,726 |
09/05/24 | 2.01 | 2.09 | 2.00 | 2.07 | 16,435 |
08/05/24 | 2.09 | 2.12 | 2.05 | 2.10 | 13,587 |
07/05/24 | 2.14 | 2.21 | 1.95 | 2.04 | 52,454 |
06/05/24 | 2.33 | 2.37 | 2.16 | 2.16 | 49,142 |
03/05/24 | 2.37 | 2.40 | 2.28 | 2.30 | 44,596 |
02/05/24 | 2.35 | 2.47 | 2.35 | 2.47 | 15,716 |
|
|
||||
|
|
||||
|
|